Skip to main content
Caplight Logo









The Silverstein Foundation for Parkinson's with GBA

The Silverstein Foundation for Parkinson's with GBA

New York City, New Yorksilversteinfoundation.org

Overview

The Silverstein Foundation for Parkinson's with GBA is a non-profit foundation that invests in cutting-edge research to discover and accelerate new therapies for the treatment of Parkinson's Disease in glucocerebrosidase (GBA) mutation carriers.

Year Founded

2017

Portfolio Companies

2

Investments

The Silverstein Foundation for Parkinson's with GBA investments
CompanyDateStageLead
Acurex BiosciencesAug 2021GrantCo-investor
Lysoway TherapeuticsJan 2023GrantCo-investor

Key People

Jonathan Silverstein

President and Co-Founder

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Portfolio analytics

Caplight clients see full sector, stage and valuation breakdowns for this investor.

Book a demo to see full analytics

For institutional investors. Book with your work email.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Portfolio analytics

Caplight clients see yearly investment pace and funding raised over time.

Book a demo to see full analytics

For institutional investors. Book with your work email.

FAQ

Where is The Silverstein Foundation for Parkinson's with GBA based?

The Silverstein Foundation for Parkinson's with GBA is headquartered in New York City, New York, United States.

When was The Silverstein Foundation for Parkinson's with GBA founded?

The Silverstein Foundation for Parkinson's with GBA was founded in 2017.

How many portfolio companies does The Silverstein Foundation for Parkinson's with GBA have?

The Silverstein Foundation for Parkinson's with GBA has 2 portfolio companies in Caplight's dataset.

What are some companies in The Silverstein Foundation for Parkinson's with GBA's portfolio?

Portfolio companies visible on Caplight include Acurex Biosciences, Lysoway Therapeutics.

What was The Silverstein Foundation for Parkinson's with GBA's most recent investment shown here?

The Silverstein Foundation for Parkinson's with GBA's most recent investment in this portfolio sample was in Lysoway Therapeutics in 2023.

What sectors does The Silverstein Foundation for Parkinson's with GBA focus on?

The Silverstein Foundation for Parkinson's with GBA focuses on Healthcare & Life Sciences, Healthcare & Life Sciences.

What company stages does The Silverstein Foundation for Parkinson's with GBA focus on?

Stage focus information for The Silverstein Foundation for Parkinson's with GBA is not publicly available.

What is The Silverstein Foundation for Parkinson's with GBA's AUM?

The Silverstein Foundation for Parkinson's with GBA's assets under management are estimated between $320.0K and $1.5M.

Firmographic Details

HeadquartersNew York City, New York
Year Founded2017

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?